Rotavirus Vaccine. Statement of the Consultive Committee of Immunizations on behalf of The Chilean Infectious Diseases Society. March 2006

The article briefly reviews the epidemiology of rotavirus infection and the scientific information of the rotavirus vaccines: Rotashield, withdrawn from the market due to its association with intussusception, Rotateq currently in an advanced phase of development, and Rotarix, recently licensed in Ch...

Full description

Saved in:
Bibliographic Details
Published in:Revista chilena de infectología 2006-06, Vol.23 (2), p.124-127
Main Authors: Muñoz M, Alma, Abarca V, Katia, Luchsinger F, Vivian, Valenzuela B, M Teresa, Jiménez de la J, Jorge
Format: Article
Language:Spanish
Subjects:
Advisory Committees
Age Factors
Animals
Cattle
Chile - epidemiology
Drug Approval
Gastroenteritis - virology
Humans
Infant
Intussusception - etiology
Rotavirus Infections - epidemiology
Rotavirus Infections - prevention & control
Rotavirus Vaccines - administration & dosage
Rotavirus Vaccines - adverse effects
Rotavirus Vaccines - immunology
Societies, Medical
Vaccines, Attenuated - administration & dosage
Vaccines, Attenuated - adverse effects
Vaccines, Attenuated - immunology
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The article briefly reviews the epidemiology of rotavirus infection and the scientific information of the rotavirus vaccines: Rotashield, withdrawn from the market due to its association with intussusception, Rotateq currently in an advanced phase of development, and Rotarix, recently licensed in Chile. Considering the available information, the Consultive Committee of Immunizations of the Chilean Society of Infectious Diseases, summarizes its conclusions and makes recommendations for infants vaccination against rotavirus in our country.
ISSN:0716-1018